1. Clearance of antipyrine-dependence of quantitative liver function;Andreasen, P.B.; Ranek, L.; Statland, B.E.; Tygstrup, N.;European Journal of Clinical Investigation,1974
2. Hepatic coma: the electroencephalographic pattern;Bickford, R.G.; Butt, H.R.;Journal of Clinical Investigation,1955
3. Determinants of serum antipyrine half-lives in patients with liver disease;Branch, R.A.; Herbert, C.M.; Read, A.E.;Gut,1973
4. A study of factors influencing drug disposition in chronic liver disease using the model drug (+)-propranolol;Branch, R.A.; James, J.; Read, A.E.;British Journal of Clinical Pharmacology,1976
5. The clearance of antipyrine and indocyanine green in normal subjects and patients with chronic liver disease. Clinical Pharmacology and Therapeutics;Branch, R.A.; James, J.; Read, A.E.,1976